Loading the SOTA2 catalog…
Compare drug discovery & biotech products for capabilities, deployment, pricing, and enterprise readiness. Ranked using verified practitioner feedback, product research, and enterprise trust signals.
| Company | Description | Matching products |
|---|---|---|
| Bramante Biologics Corporation | Instruments and reagents for life-sciences manufacturing, designed, assembled, and tested in Massachusetts. | |
| CNNScoreVariants | CNNScoreVariants is a variant filtering tool within the GATK (Genome Analysis Toolkit) suite that annotates a VCF with scores from a Convolutional Neural Network. | |
| CellType operates as an agentic drug company that simulates human biology using a biological world model. The company develops foundation models trained on human cellular and molecular data to predict drug response, toxicity, patient variation, and diagnostics. |
| Cellbyte | AI agents for Pricing and Market Access teams in the pharmaceutical industry. |
| Chai Discovery | Builds a computer-aided design suite for molecules, using AI to predict and reprogram biochemical molecule interactions for drug discovery. |
| Clair3 | Clair3 is a germline small variant caller for long reads developed by HKU-BAL. It combines pileup calling and full-alignment approaches for high-performance long-read variant calling. |
| Convexia | Convexia is an AI-maximalist pharma company that builds autonomous AI agents to scout, vet, and accelerate overlooked drug assets through an end-to-end sourcing and evaluation stack. |
| CryoSPARC | Structura Biotechnology Inc. develops and supports CryoSPARC, software for cryo-electron microscopy (cryo-EM) data processing used in drug discovery and research. Based in Toronto, Canada. |
| Curebase, Inc. | AI-powered eClinical technology platform company for modern clinical trials, offering integrated ePRO/eCOA, eConsent, EDC, patient recruitment, and site software. |
| Cytocast | Techbio startup using AI-powered predictive modeling to evaluate drug side effects of chemical compounds. |
| Deep Genomics | AI-driven genetic medicines platform company that collaborates across disciplines to solve molecular design and target biology problems in drug discovery. |
| DeepChain | Industry-leading biology AI solutions for life sciences R&D, built on InstaDeep's AI research. |
| Delineate | Delineate creates models from the totality of available evidence, in any therapeutic area, so development, regulatory, and commercial teams act on quantitative evidence insights in a fraction of the time. Trusted by 4 of the top 10 pharma companies. Backed by Y Combinator, MIT Sandbox, and NIH Seed. |
| DrugFlow | AI-driven one-stop new drug discovery platform covering target discovery, lead compound discovery, and lead compound optimization, using AIGC, self-supervised pre-training, and reinforcement learning integrated with physical computing. |
| Duoseq | Cancer genomics service offering on-site DNA and RNA comprehensive profiling with sample-to-report turnaround of approximately two days. |
| Exin Therapeutics, Inc. | An AI discovery platform for neurotherapeutics targeting neural circuits across disorders. |
| FinalDose | Building "The Complete Architecture for Cancer Therapy" with the approach: "DNA gives us the address. Programmability gives us the scale. Elimination gives us the cure." |
| GHOSTZ-GPU | An open-source GPU-accelerated sequence homology search tool using database subsequence clustering, hosted in the akiyamalab repository on GitHub. |
| GPMeta | A GPU-accelerated method for ultrarapid pathogen identification from metagenomic sequences. |
| GPUGRID | Volunteer computing project that harnesses GPU power for scientific research including drug discovery, protein folding, and molecular dynamics. |
| Gamgee | Developer of personalized mRNA cancer treatment protocols for dogs, managing the end-to-end process from application to treatment in collaboration with veterinary oncologists. |
| Harmonic Discovery | Harmonic Discovery is a therapeutics company leveraging machine learning, data science, and structural bioinformatics to develop next-generation medicines with precision pharmacology. The company focuses on creating multi-targeted therapeutics that address disease complexity by tuning out anti-targets and tuning in additional targets to enhance efficacy and mitigate toxicities. |
| HelixNano | Clinical-stage mRNA startup building next-generation mRNA technologies, vaccines and therapies to augment the immune system's power to fight disease. Tackling cancer with cancer vaccines targeting metastatic tumors, with an ongoing Phase 1 clinical trial for a COVID vaccine designed for immunocompromised patients. |
| Invert | Infrastructure and intelligence for bioprocess — for development and manufacturing teams at biopharma, synthetic biology, and CDMOs. |
| Keylika | Biopharmaceutical company focused on drug discovery and drug delivery, employing AI-enabled de novo drug design and nanotechnology-based transdermal delivery technologies to generate breakthrough therapies. |
| Lamar Health | Specialty Medication AI company providing workflow software that orchestrates operations for specialty pharmacies and infusion organizations, covering referral, intake, prior authorization, interoperability, and more. |
| Ligo Biosciences | Builds generative models and experimental systems for enzyme design, creating next-gen tooling to manipulate chemistry and biology. |
| META D3 | AI powered Drug Discovery and Development platform for drug discovery steps from target identification to clinical trial success, associated with Partex. |
| MUMmer GPU | MUMmer GPU is a high-throughput local sequence alignment program |
| Macromoltek | Pioneering biotech company specializing in computational modeling and artificial intelligence to design next-generation antibodies for biotech and pharmaceutical partners. |
| Matrubials, Inc. | Biotechnology company developing milk-inspired antibacterial therapeutics for infectious diseases, spun off from the Foods For Health Institute at UC Davis. |
| Medium Biosciences | Designs experimentally validated custom affinity reagents for specific targets and applications, leveraging AI and protein design advances. Partners with research teams and diagnostic developers to deliver molecular tools in weeks. |
| MuSE | Somatic point mutation caller for tumor-normal paired samples in next-generation sequencing data, developed at the Department of Bioinformatics and Computational Biology at MD Anderson Cancer Center. Based on a Markov substitution model for molecular evolution with a sample-specific error model. |
| NVIDIA (NVLabs) | Company behind NVBIO, a GPU-accelerated bioinformatics library. | nvBowtie 2 more |
| NYB | AI-first drug discovery and nutraceuticals company that advances therapeutics and nutraceuticals through an integrated discovery platform. |
| Nanograb | Nanograb develops generative AI approaches to design nanoparticles for cell-selective drug delivery, aiming to enable drugs to treat diseases without side effects. |
| NeuSomatic | NeuSomatic is a deep convolutional neural network-based method for accurate somatic mutation detection, hosted under the GitHub organization "bioinform". |
| Numerion Labs | AI drug discovery company using a machine-learning superplatform to explore chemical space for novel drug-like molecules. |
| OneKind AI | AI-originated clinical endpoints for companion animal drug development. Validated, audit-ready behavioral endpoints for pharma R&D and CROs. |
| Ontosight Terminal | AI-powered intelligence unifying clinical, scientific, and competitive insights to accelerate drug development. |
| Output Biosciences | A fully integrated AI lab building Artificial General Biological Intelligence (AGBI), from the molecular level up to whole systems. |
| PEANUT | A read mapper for DNA or RNA sequence reads that aligns biological sequencing reads to a known reference genome using GPU parallelism and a novel q-group index data structure. |
| PEPPER | A genome inference module based on recurrent neural networks that enables long-read variant calling and nanopore assembly polishing in the PEPPER-Margin-DeepVariant pipeline. |
| Pando Bioscience | AI-driven synthetic biology company that discovers and designs high-performance enzymes with AI-guided iterative improvement for pharma manufacturing and life science tools. |
| Persist AI | Biotechnology company combining AI and robotics for high-throughput pharmaceutical formulation development, focusing on long-acting injectables, amorphous solid dispersions, parenterals, creams, and in-situ depots. |
| Phases | Phases is an AI platform for clinical trial operations that integrates with existing systems, provides oversight, and takes action across trial workflows. |
| PyMOL | A user-sponsored molecular visualization system on an open-source foundation, maintained and distributed by Schrödinger. |
| Reticular | Y Combinator–backed company focused on scaling genomic AI for embryo selection and IVF risk reporting, offering at-home partner screening and reanalysis of existing PGT-A embryo data. |
| Rosebud Biosciences | Early-stage startup developing therapies for rare genetic diseases in children by modeling human development with patient-matched organoids to screen drugs for cures. |
| SFA Therapeutics, Inc. | Clinical-stage biopharmaceutical company developing oral immune tolerance therapies for psoriasis and other autoimmune and oncology indications using a proprietary deuterated short-chain fatty acid platform. |